Could a super multivitamin give babies a healthier start in life?

NCT ID NCT07029282

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a new multivitamin supplement (MMS Plus) given during pregnancy and after birth can improve infant health and growth compared to standard multivitamins or iron/folic acid. About 3,000 pregnant women in Pakistan will take the supplements and be followed until their babies are 6 months old. The goal is to reduce complications like stillbirth, preterm birth, and poor growth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multiple micronutrient supplements (MMS Plus, standard MMS, and iron/folic acid)
What this could lead to
If it works, this could point toward a better prenatal and postnatal supplement to reduce infant deaths and improve growth in low-resource settings.
What could go wrong
This is a large phase 3 trial, but results may not apply to other populations. The supplements are generally safe, but individual allergies or intolerances are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADAPTIVE TRIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Peri-Urban Slums of Karachi (Ali Akber Shah, Bhains Colony)

    RECRUITING

    Karachi, Sindh, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.